Yabut Jevin, Lima Gian, Vankina Ritika, Kumar Swarup, Meng Joyce
Medicine, University of Connecticut, Farmington, USA.
Internal Medicine, University of Connecticut, Farmington, USA.
Cureus. 2023 May 4;15(5):e38549. doi: 10.7759/cureus.38549. eCollection 2023 May.
Thrombotic events are a rare complication of recombinant activated factor VII (rFVIIa) therapy in patients with hemophilia. We present a case of a 71-year-old male who developed ST-elevation myocardial infarction after receiving rFVIIa replacement therapy for acquired hemophilia A.
血栓形成事件是血友病患者接受重组活化凝血因子VII(rFVIIa)治疗时罕见的并发症。我们报告一例71岁男性患者,其在接受rFVIIa替代疗法治疗获得性甲型血友病后发生了ST段抬高型心肌梗死。